[1]
Bako, H.Y. 2024. Impact of Tofacitinib and Aspirin on Lipoprotein Levels in Type 2 diabetic Rats: Implications for Macrovascular Complications’ Risk Mitigation. UMYU Scientifica. 3, 3 (Aug. 2024), 159–165. DOI:https://doi.org/10.56919/usci.2433.018.